Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 249,588 | 71,435 | 183,033 | 190,514 | 183,247 |
| Marketable Securities | 53,235 | 90,573 | N/A | 10,493 | 27,945 |
| Receivables | N/A | N/A | 500 | 500 | 500 |
| TOTAL | $305,633 | $165,178 | $186,430 | $205,196 | $213,929 |
| Non-Current Assets | |||||
| PPE Net | 9,653 | 9,225 | 8,402 | 5,125 | 3,798 |
| Other Non-Current Assets | 24,921 | 25,474 | 26,033 | 2,711 | 2,227 |
| TOTAL | $34,574 | $34,699 | $34,435 | $7,836 | $6,025 |
| Total Assets | $340,207 | $199,877 | $220,865 | $213,032 | $219,954 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,932 | 5,447 | 3,941 | 2,438 | 3,264 |
| Accounts payable and accrued liabilities | 5,715 | 5,410 | 5,367 | 4,205 | 5,236 |
| Accrued Expenses | 13,843 | 9,834 | 9,950 | 10,926 | 9,638 |
| Other current liabilities | 2,106 | 2,106 | 2,106 | 2,106 | 1,284 |
| TOTAL | $40,595 | $29,418 | $29,140 | $27,263 | $22,672 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 9,469 | 10,958 | 12,446 | 11,601 |
| Deferred Revenues | 3,367 | 5,049 | 6,576 | 7,588 | 3,250 |
| Other Non-Current Liabilities | 27,074 | 28,220 | 28,550 | 5,354 | 3,752 |
| TOTAL | $31,570 | $42,933 | $45,888 | $25,300 | $23,353 |
| Total Liabilities | $72,165 | $72,351 | $75,028 | $52,563 | $46,025 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,593 | 65,386 | 65,186 | 65,000 | 64,519 |
| Common Shares | 75 | 65 | 65 | 65 | 65 |
| Retained earnings | -355,243 | -328,634 | -305,156 | -285,396 | -269,369 |
| Other shareholders' equity | 54 | 96 | 3 | 1 | -11 |
| TOTAL | $268,042 | $127,526 | $145,837 | $160,469 | $173,929 |
| Total Liabilities And Equity | $340,207 | $199,877 | $220,865 | $213,032 | $219,954 |